Detalles de la búsqueda
1.
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.
Hum Vaccin Immunother;
19(2): 2233400, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37438960
Resultados
1 -
1
de 1
1
Próxima >
>>